Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006298-26Phase 3Completed
Phase 3, randomised, double-blind trial of diractin in knee osteoarthritis (OA) and osteoarthritis (OA) (4 arms), sponsored by IDEA AG. Primary endpoint: Primary efficacy endpoint. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006298-26.